"I am really a big proponent of this software and what it brings to the pathology profession in terms of the ease of work; it just really simplifies our process of working in almost every single way and there’s no loss of detail. I'm sure it's going to make us all better pathologists"
Fast viewing performance with advanced ergonomics that meet industry needs
Highly customizable study design incorporating vendor-agnostic WSI
Software as a Service model with low administrative costs
Highly secure sharing of studies between remote Pharma and CRO partners
Infinitely-scalable repository that grows in line with your organizational needs
Affordable, straightforward service models ensures you pay for only what you need
Designed in close collaboration with industry experts, Patholytix Preclinical integrates innovative workflow design with best of breed ergonomics to deliver a truly unique digital pathology experience tailored to the specific needs of toxicological pathologists in Pharma and CRO alike. Our unique architecture design is a revolution in Digital Pathology deployment, and helps you to deliver tangible cost and time savings to your pathologists, and to your organization.
Patholytix preclinical offers a blend of workflow design, viewing performance and ease of use that delivers a truly unique digital pathology experience. Every aspect of our solution has been carefully tailored to the specific needs of pathologists in Pharma and CROs. Our collaborative approach has given us the opportunity to understand the real challenges faced by our users and with Patholytix preclinical, we deliver solutions that matter to you, and your organization.
Complex animal models generate large amounts of data, where no two studies will contain the same type or quantity of data. Patholytix preclinical offers complete control over the structure of your studies, supporting any type of associated data (microscopic, macroscopic, in-life) for any size of study (short term, chronic, carcinogenicity) within a simple, intuitive interface. With full support for a variety of WSI vendor formats along with SEND data representation and LIMS integration capabilities, Patholytix helps achieve standardization and efficiency across your pathology process.
On-demand collaboration between remote Pharma and CRO partners is a fundamental need in toxicologic pathology. Patholytix preclinical provides a revolutionary cloud-based infrastructure to facilitate connectivity between collaborating partners from any location around the world. Studies can be published and shared with nominated partners at the push of a button, providing you with a faster and smarter way to complete peer reviews.
With Patholytix preclinical, you can be assured that your data remains secure at every point in our ecosystem – from the moment you upload a study, to the point a remote partner completes their review. We have designed our platform leveraging principles and practices from the financial services sector, and maintain continued effort in understanding how to ensure we keep our customers data secure through close collaborating with industry experts and Pharma / CRO partners.
Patholytix preclinical 2.0 incorporates technical controls required to facilitate validation and provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners. The technical controls in the product support computer systems validation in the context of FDA and OECD guidelines and regulations. We have also augmented internal process controls to facilitate vendor GLP compliance so the outputs of our development processes can be used as inputs to the client validation process.
Experience Patholytix Preclinical for yourself. To arrange a demo, click the link below and complete the form.request a demo
Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology.Read more
At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners.Read more
To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders.Read more